Inactivation of cysteine 674 in the SERCA2 accelerates experimental aortic aneurysm

J Mol Cell Cardiol. 2020 Feb:139:213-224. doi: 10.1016/j.yjmcc.2020.02.003. Epub 2020 Feb 5.

Abstract

Sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) is vital to maintain intracellular calcium homeostasis. SERCA2 cysteine 674 (C674) is highly conservative and its irreversible oxidation is upregulated in human and mouse aortic aneurysms, especially in smooth muscle cells (SMCs). The contribution of SERCA2 and its redox C674 in the development of aortic aneurysm remains enigmatic. Objective: Our goal was to investigate the contribution of inactivation of C674 to the development of aortic aneurysm and the mechanisms involved. Approach and results: Using SERCA2 C674S knock-in (SKI) mouse line, in which half of C674 was substituted by serine 674 (S674) to represent partial irreversible oxidation of C674 in aortic aneurysm, we found that in aortic SMCs the replacement of C674 by S674 resulted in SMC phenotypic modulation. In SKI SMCs, the increased intracellular calcium activated calcium-dependent calcineurin, which promoted the nuclear translocation of nuclear factor of activated T-lymphocytes (NFAT) and nuclear factor kappa-B (NFκB), while inhibition of calcineurin blocked SMC phenotypic modulation. Besides, the replacement of C674 by S674 accelerated angiotensin II-induced aortic aneurysm. Conclusions: Our results indicate that the inactivation of C674 by causing the accumulation of intracellular calcium to activate calcineurin-mediated NFAT/NFκB pathways, resulted in SMC phenotypic modulation to accelerate aortic aneurysm, which highlights the importance of C674 redox state in the development of aortic aneurysms.

Keywords: Aortic aneurysm; Calcineurin; NFAT; Phenotypic modulation; SERCA2; Smooth muscle cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II
  • Animals
  • Aortic Aneurysm / enzymology*
  • Aortic Aneurysm / genetics*
  • Aortic Aneurysm / pathology
  • Calcineurin / metabolism
  • Cholesterol / blood
  • Cysteine / genetics*
  • Cysteine / metabolism
  • Down-Regulation / genetics
  • Humans
  • Mice, Inbred C57BL
  • Myocytes, Smooth Muscle / metabolism
  • NF-kappa B / metabolism
  • NFATC Transcription Factors / metabolism
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • Oxidation-Reduction
  • Phenotype
  • Receptors, LDL / metabolism
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics*
  • Signal Transduction
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Triglycerides / blood
  • Up-Regulation / genetics

Substances

  • NF-kappa B
  • NFATC Transcription Factors
  • Nuclear Proteins
  • Receptors, LDL
  • Trans-Activators
  • Triglycerides
  • myocardin
  • Osteopontin
  • Angiotensin II
  • Cholesterol
  • Calcineurin
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Cysteine